NCM · Medical - Diagnostics & Research

bioAffinity Technologies, Inc. (BIAF) Stock

$4.72 -16.22% NCM: BIAF Healthcare

Valuation

MetricValue
Price$4.72
Market Cap$1.98M
P/E Ratio-0.05
P/B Ratio0.56
P/S Ratio0.43
EPS (TTM)$0.00
52-Week High$80.70
52-Week Low$4.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-257.27%
ROA-199.30%
ROCE-250.72%
Gross Margin-183.33%
Operating Margin-183.33%
Net Margin-257.33%
Debt/Equity0.38
Current Ratio2.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$3.0M$9.0M$6.0M
Operating Profit$-2.0M$-4.0M$-8.0M$-9.0M$-11.0M
Net Profit$-6.0M$-8.0M$-8.0M$-9.0M$-15.0M
EPS$-1043.55$-814.50$-409.50$-337.50$-129.90
Op Margin—-83511.5%-314.9%-95.6%-171.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$12.0M$8.0M$7.0M$11.0M
Total Liabilities$17.0M$1.0M$3.0M$4.0M$4.0M
Cash$1.0M$11.0M$3.0M$1.0M$6.0M
Borrowings$11.0M$0$2.0M$2.0M$1.0M

Latest News

bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD Business Wire · Jul 22, 2026 BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell? Zacks · Jul 9, 2026 bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues Business Wire · Jul 7, 2026 Q2 Virtual Investor Summit Presentations Now Available On Demand ACCESS Newswire · Jun 30, 2026 Q2 Investor Summit Virtual Live Wednesday June 24 ACCESS Newswire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-4.0M$-6.0M$-7.0M$-9.0M
Investing Cash Flow$0$0$-2.0M$0$0
Financing Cash Flow$0$8.0M$0$1.0M$0
Net Cash Flow$1.0M$10.0M$-9.0M$-2.0M$5.0M
Free Cash Flow$-2.0M$-4.0M$-6.0M$-7.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.10
FCF Yield-453.41%
Quick Ratio1.41
Interest Coverage-276.15
Return 1Y-91.78%
Return 3Y-98.64%
Return 5Y—

Ownership

Insiders Held2.29%
Institutions Held6.44%
Institutions Float Held6.59%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC55,5432026-03-31
Geode Capital Management, LLC48,2932026-03-31
J. Safra Sarasin Holding AG42,6002026-03-31
Vanguard Fiduciary Trust Co31,0712026-03-31
Schonfeld Strategic Advisors Llc24,4132026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. is led by CEO Maria Zannes, publicly traded since 2022.

bioAffinity Technologies, Inc. (BIAF) stock trades at $4.72 with a market capitalization of $1.98M. The stock is valued at a price-to-earnings (P/E) ratio of -0.05, price-to-book of 0.56, price-to-sales of 0.43. Over the past 52 weeks the stock has ranged between $4.56 and $80.70, and currently trades 94.2% below its 52-week high.

On profitability, bioAffinity Technologies, Inc. generates a return on equity (ROE) of -257.27%, return on capital employed of -250.72%, an operating margin of -183.33%, a net profit margin of -257.33%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides